Overview of data concerning the safe use of antihyperglycemic medications in type 2 diabetes mellitus and chronic kidney disease

R Roussel, J Lorraine, A Rodriguez… - Advances in …, 2015 - Springer
Introduction It can be a challenge to manage glycemic control in patients with type 2
diabetes mellitus (T2DM) and chronic kidney disease (CKD), due to both patient and …

[HTML][HTML] Effective treatment recommendations for type 2 diabetes management using reinforcement learning: treatment recommendation model development and …

X Sun, YM Bee, SW Lam, Z Liu, W Zhao… - Journal of Medical …, 2021 - jmir.org
Background Type 2 diabetes mellitus (T2DM) and its related complications represent a
growing economic burden for many countries and health systems. Diabetes complications …

LX4211 therapy reduces postprandial glucose levels in patients with type 2 diabetes mellitus and renal impairment despite low urinary glucose excretion

B Zambrowicz, P Lapuerta, P Strumph, P Banks… - Clinical …, 2015 - Elsevier
Purpose We sought to assess the efficacy and safety profile of LX4211, a dual inhibitor of
sodium-glucose cotransporter1 (SGLT1) and SGLT2, in patients with type 2 diabetes and …

Pregnancy outcomes among renal transplant recipients and patients with end-stage renal disease on dialysis

S Saliem, V Patenaude, HA Abenhaim - Journal of Perinatal …, 2016 - degruyter.com
Aim: The purpose of our study is to compare pregnancy outcomes between women with a
functioning renal transplant and women with end-stage renal disease (ESRD). Methods: We …

Noninsulin antidiabetic drugs for patients with type 2 diabetes mellitus: are we respecting their contraindications?

I Ruiz-Tamayo, J Franch-Nadal… - Journal of Diabetes …, 2016 - Wiley Online Library
Aim. To assess prescribing practices of noninsulin antidiabetic drugs (NIADs) in T2DM with
several major contraindications according to prescribing information or clinical guidelines …

Influence of guideline adherence and parameter control on the clinical outcomes in patients with diabetic nephropathy

J Lu, W Zhao, T Chen, Z Xu, X Sun, H Xie… - BMJ Open Diabetes …, 2020 - drc.bmj.com
Introduction We assessed the association between guideline adherence and outcomes of
clinical parameter control and end-stage kidney disease (ESKD), and further studied the …

Oral antidiabetics use among diabetic type 2 patients with chronic kidney disease. Do nephrologists take account of recommendations?

C Muller, Y Dimitrov, O Imhoff, S Richter, J Ott… - Journal of Diabetes and …, 2016 - Elsevier
Background There is an increasing prevalence of diabetes type 2 and chronic kidney
disease, challenging appropriate prescribing of oral anti-diabetic drugs (OADs). Methods …

Interventions developed to reduce secondary care utilisation in patients with type 2 diabetes mellitus: a narrative review

SM Khayyat, PA Walters, C Whittlesea… - International Journal of …, 2022 - academic.oup.com
Objectives To identify, describe and critically appraise the quality of studies of interventions
developed to reduce the rate of secondary care utilisation and investigate interventions' …

Should we care to adhere? Guideline adherence rates, glycemic control and physician perspective on adherence for type-2 diabetes

S Brenner, W Oberaigner, H Stummer - Journal of Public Health, 2021 - Springer
Background and aim Despite increasing knowledge, treatment options and funding, the
number of type-2 diabetes mellitus (T2DM) patients who achieve their glycemic targets has …

Improving anticoagulant treatment strategies of atrial fibrillation using reinforcement learning

L Zuo, X Du, W Zhao, C Jiang, S Xia… - AMIA Annual …, 2021 - pmc.ncbi.nlm.nih.gov
In this paper, we developed a personalized anticoagulant treatment recommendation model
for atrial fibrillation (AF) patients based on reinforcement learning (RL) and evaluated the …